Turning sugar into pure, pharma-grade rare cannabinoids: the company’s breakthrough
In an exclusive interview with Benzinga, Dr. Shane Johnson, MDSenior vice president and general manager of BayMedicaShed light on the company’s innovative approach to cannabinoid production. With a background in cannabis and cannabinoid science, and credentials from Stanford University School of Medicine, Dr. Johnson is at the forefront of the scientific revolution. How could BayMedica’s…